What is the current annual SG&A of ABBV?

As of today, ABBV annual SG&A is $0.00

What is 1-year change in ABBV annual SG&A?

ABBV annual SG&A is down -100.00% year-over-year

What is 3-year change in ABBV annual SG&A?

ABBV annual SG&A is down -100.00% over the past 3 years

How far is ABBV annual SG&A from its all-time high?

ABBV annual SG&A is currently -100.00% below its historical high of $15.26B set on December 31, 2022

How does ABBV annual SG&A rank versus sector peers?

ABBV annual SG&A is higher than 73.28% of companies in Healthcare sector

When is ABBV next annual earnings release?

As of today, the next annual earnings release for ABBV has not been scheduled

What is the current quarterly SG&A of ABBV?

As of today, ABBV quarterly SG&A is $3.63B

What is ABBV quarterly SG&A most recent change?

ABBV quarterly SG&A was up +1.51% on June 30, 2026

What is 1-year change in ABBV quarterly SG&A?

ABBV quarterly SG&A is up +11.65% year-over-year

How far is ABBV quarterly SG&A from its all-time high?

ABBV quarterly SG&A is currently -32.89% below its historical high of $5.41B set on June 30, 2022

How does ABBV quarterly SG&A rank versus sector peers?

ABBV quarterly SG&A is higher than 99.63% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on October 29, 2026

What is the current TTM SG&A of ABBV?

As of today, ABBV TTM SG&A is -$64.93B

What is ABBV TTM SG&A most recent change?

ABBV TTM SG&A was down -9.86% on June 30, 2026

What is 1-year change in ABBV TTM SG&A?

ABBV TTM SG&A is down -544.56% year-over-year

How does ABBV TTM SG&A rank versus sector peers?

ABBV TTM SG&A is higher than 0.27% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on October 29, 2026

AbbVie Inc. (ABBV) SG&A History & Chart Since 2009

Annual SG&A

$0.00$14.75B-100.00%

December 31, 2025

Summary

Current Value: As of today, ABBV annual SG&A is $0.00, down -100.00% on December 31, 2025
Historical Performance: ABBV annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
All-Time High Comparison: ABBV annual SG&A is currently -100.00% below its historical high of $15.26B set on December 31, 2022
Sector Comparison: ABBV annual SG&A is higher than 73.28% of companies in Healthcare sector

SG&A Chart

beforeafter

Performance

ABBV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Jun 30, 26	$3.63B	+11.7%	+11.1%	+14.8%	+248.9%
TTM SG&A	Jun 30, 26	-$64.93B	-544.6%	-598.4%	-637.4%	-3026.3%
Price	Aug 5, 26	$246.20	+24.0%	+66.7%	+113.9%	–
Annual Operating Expenses	Dec 31, 25	$29.98B	+31.1%	+57.7%	+86.7%	+387.5%
Annual Operating Profit	Dec 31, 25	$21.21B	+27.6%	-6.1%	+35.7%	+311.4%
Annual D&A	Dec 31, 25	$8.14B	-3.0%	-3.9%	+25.8%	+587.2%
Annual Revenue	Dec 31, 25	$61.16B	+8.6%	+5.3%	+33.5%	+291.1%

SG&A Highs

ABBV Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$15.26B	N/A	-100.0%
5Y	$15.26B	Dec 31, 22	-100.0%
All	$15.26B	Dec 31, 22	-100.0%

SG&A Lows

ABBV Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$0.00	Dec 31, 25	N/A
5Y	$0.00	Dec 31, 25	N/A
All	$0.00	Dec 31, 25	N/A

SG&A History

Year	Value	Change
2025	$0.00	-100.0%
2024	$14.75B	+14.6%
2023	$12.87B	-15.6%
2022	$15.26B	+23.6%
2021	$12.35B	+9.3%
2020	$11.30B	+62.8%
2019	$6.94B	-6.2%
2018	$7.40B	+17.5%
2017	$6.30B	+7.5%

Year	Value	Change
2016	$5.86B	-8.3%
2015	$6.39B	-17.3%
2014	$7.72B	+44.3%
2013	$5.35B	+7.3%
2012	$4.99B	-15.4%
2011	$5.89B	+54.3%
2010	$3.82B	+14.1%
2009	$3.35B	-

FAQ

What is the current annual SG&A of ABBV?: As of today, ABBV annual SG&A is $0.00
What is 1-year change in ABBV annual SG&A?: ABBV annual SG&A is down -100.00% year-over-year
What is 3-year change in ABBV annual SG&A?: ABBV annual SG&A is down -100.00% over the past 3 years
How far is ABBV annual SG&A from its all-time high?: ABBV annual SG&A is currently -100.00% below its historical high of $15.26B set on December 31, 2022
How does ABBV annual SG&A rank versus sector peers?: ABBV annual SG&A is higher than 73.28% of companies in Healthcare sector
When is ABBV next annual earnings release?: As of today, the next annual earnings release for ABBV has not been scheduled

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Quarterly SG&A

$3.63B$54.00M+1.51%

June 30, 2026

Summary

Current Value: As of today, ABBV quarterly SG&A is $3.63B, up +1.51% on June 30, 2026
Historical Performance: ABBV quarterly SG&A is up +11.65% year-over-year, up +11.14% over the past 3 years
All-Time High Comparison: ABBV quarterly SG&A is currently -32.89% below its historical high of $5.41B set on June 30, 2022
3-Year Low Comparison: ABBV quarterly SG&A is +13.75% above its 3-year low of $3.19B reached on December 31, 2023
Sector Comparison: ABBV quarterly SG&A is higher than 99.63% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Jun 30, 26	$3.63B	+1.5%	+11.7%	+11.1%	+14.8%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
TTM SG&A	Jun 30, 26	-$64.93B	-554.2%	-544.6%	-598.4%	-637.4%
Price	Aug 5, 26	$246.20	+19.4%	+24.0%	+66.7%	+113.9%
Quarterly Operating Expenses	Jun 30, 26	$7.67B	+32.9%	+46.1%	+55.5%	+57.9%
Quarterly Operating Profit	Jun 30, 26	$6.72B	+33.8%	+15.9%	+41.5%	+45.3%
Quarterly D&A	Jun 30, 26	$1.88B	-2.7%	-8.2%	-16.7%	-14.4%
Quarterly Revenue	Jun 30, 26	$16.99B	+13.3%	+10.2%	+22.5%	+21.7%

Quarterly SG&A Highs

ABBV Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$3.90B	Dec 31, 25	-6.8%
3Y	$4.21B	Sep 30, 24	-13.6%
5Y	$5.41B	Jun 30, 22	-32.9%
All	$5.41B	Jun 30, 22	-32.9%

Quarterly SG&A Lows

ABBV Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$3.25B	N/A	+11.7%
3Y	$3.19B	Dec 31, 23	+13.8%
5Y	$3.04B	Mar 31, 23	+19.5%
All	$1.04B	Jun 30, 11	+248.9%

Quarterly SG&A History

Month	Value	Change
Jun 2026	$3.63B	+1.5%
Mar 2026	$3.58B	-8.1%
Dec 2025	$3.90B	+9.1%
Sep 2025	$3.57B	+9.7%
Jun 2025	$3.25B	-1.2%
Mar 2025	$3.29B	-14.6%
Dec 2024	$3.86B	-8.3%
Sep 2024	$4.21B	+24.5%
Jun 2024	$3.38B	+1.9%
Mar 2024	$3.32B	+3.8%
Dec 2023	$3.19B	-5.3%
Sep 2023	$3.37B	+3.2%
Jun 2023	$3.27B	+7.5%
Mar 2023	$3.04B	-11.1%
Dec 2022	$3.42B	+3.4%
Sep 2022	$3.30B	-39.0%
Jun 2022	$5.41B	+73.1%
Mar 2022	$3.13B	-4.1%
Dec 2021	$3.26B	+5.7%
Sep 2021	$3.08B	-2.6%
Jun 2021	$3.16B	+11.3%
Mar 2021	$2.84B	-12.0%
Dec 2020	$3.23B	+13.5%
Sep 2020	$2.85B	-19.3%
Jun 2020	$3.53B	+108.1%
Mar 2020	$1.70B	-13.1%
Dec 2019	$1.95B	+17.7%
Sep 2019	$1.66B	+0.2%
Jun 2019	$1.65B	-1.5%
Mar 2019	$1.68B	-12.9%
Dec 2018	$1.93B	+0.5%

Month	Value	Change
Sep 2018	$1.92B	+9.0%
Jun 2018	$1.76B	-1.7%
Mar 2018	$1.79B	-8.4%
Dec 2017	$1.96B	+34.2%
Sep 2017	$1.46B	-3.1%
Jun 2017	$1.50B	+9.9%
Mar 2017	$1.37B	-17.2%
Dec 2016	$1.65B	+19.7%
Sep 2016	$1.38B	-5.8%
Jun 2016	$1.47B	+8.2%
Mar 2016	$1.36B	-22.0%
Dec 2015	$1.74B	+17.8%
Sep 2015	$1.47B	-13.4%
Jun 2015	$1.70B	+15.6%
Mar 2015	$1.47B	-55.9%
Dec 2014	$3.34B	+109.5%
Sep 2014	$1.60B	+10.2%
Jun 2014	$1.45B	+8.1%
Mar 2014	$1.34B	-7.5%
Dec 2013	$1.45B	+14.8%
Sep 2013	$1.26B	-10.3%
Jun 2013	$1.41B	+13.7%
Mar 2013	$1.24B	-12.3%
Dec 2012	$1.41B	+29.9%
Sep 2012	$1.09B	-12.9%
Jun 2012	$1.25B	-0.1%
Mar 2012	$1.25B	+10.0%
Dec 2011	$1.13B	-55.4%
Sep 2011	$2.54B	+144.1%
Jun 2011	$1.04B	-11.6%
Mar 2011	$1.18B	-

FAQ

What is the current quarterly SG&A of ABBV?: As of today, ABBV quarterly SG&A is $3.63B
What is ABBV quarterly SG&A most recent change?: ABBV quarterly SG&A was up +1.51% on June 30, 2026
What is 1-year change in ABBV quarterly SG&A?: ABBV quarterly SG&A is up +11.65% year-over-year
How far is ABBV quarterly SG&A from its all-time high?: ABBV quarterly SG&A is currently -32.89% below its historical high of $5.41B set on June 30, 2022
How does ABBV quarterly SG&A rank versus sector peers?: ABBV quarterly SG&A is higher than 99.63% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on October 29, 2026

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

TTM SG&A

-$64.93B$5.83B-9.86%

June 30, 2026

Summary

Current Value: As of today, ABBV TTM SG&A is -$64.93B, down -9.86% on June 30, 2026
Historical Performance: ABBV TTM SG&A is down -544.56% year-over-year, down -598.40% over the past 3 years
All-Time High Comparison: ABBV TTM SG&A is currently -382.07% below its historical high of $23.02B set on an earlier date
3-Year Low Comparison: ABBV TTM SG&A is at its 3-year low
Sector Comparison: ABBV TTM SG&A is higher than 0.27% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Jun 30, 26	-$64.93B	-554.2%	-544.6%	-598.4%	-637.4%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Jun 30, 26	$3.63B	+1.5%	+11.7%	+11.1%	+14.8%
Price	Aug 5, 26	$246.20	+19.4%	+24.0%	+66.7%	+113.9%
TTM Operating Profit	Jun 30, 26	$22.02B	+4.4%	+19.4%	-1.9%	+29.2%
TTM D&A	Jun 30, 26	$7.87B	-2.1%	-4.8%	-10.1%	-10.3%
TTM Revenue	Jun 30, 26	$64.39B	+2.5%	+10.4%	+14.9%	+19.8%

TTM SG&A Highs

ABBV TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	-$33.89B	N/A	-91.6%
3Y	$13.92B	N/A	-566.5%
5Y	$18.36B	N/A	-453.7%
All	$23.02B	N/A	-382.1%

TTM SG&A Lows

ABBV TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	-$64.93B	N/A	at low
3Y	-$64.93B	N/A	at low
5Y	-$64.93B	N/A	at low
All	-$64.93B	N/A	at low

TTM SG&A History

Month	Value	Change
Jun 2026	$14.67B	+2.7%
Mar 2026	$14.30B	+2.0%
Dec 2025	$14.01B	+0.3%
Sep 2025	$13.97B	-4.4%
Jun 2025	$14.61B	-0.8%
Mar 2025	$14.73B	-0.1%
Dec 2024	$14.75B	+4.7%
Sep 2024	$14.09B	+6.3%
Jun 2024	$13.26B	+0.8%
Mar 2024	$13.15B	+2.1%
Dec 2023	$12.87B	-1.7%
Sep 2023	$13.10B	+0.5%
Jun 2023	$13.03B	-14.1%
Mar 2023	$15.17B	-0.6%
Dec 2022	$15.26B	+1.0%
Sep 2022	$15.10B	+1.5%
Jun 2022	$14.88B	+17.8%
Mar 2022	$12.63B	+2.3%
Dec 2021	$12.35B	+0.2%
Sep 2021	$12.32B	+2.0%
Jun 2021	$12.08B	-2.9%
Mar 2021	$12.45B	+10.2%
Dec 2020	$11.30B	+12.8%
Sep 2020	$10.02B	+13.5%
Jun 2020	$8.83B	+26.9%
Mar 2020	$6.96B	+0.2%
Dec 2019	$6.94B	+0.3%
Sep 2019	$6.92B	-3.6%
Jun 2019	$7.18B	-1.5%
Mar 2019	$7.29B	-1.5%
Dec 2018	$7.40B	-0.4%

Month	Value	Change
Sep 2018	$7.43B	+6.6%
Jun 2018	$6.96B	+3.8%
Mar 2018	$6.71B	+6.7%
Dec 2017	$6.29B	+5.1%
Sep 2017	$5.98B	+1.3%
Jun 2017	$5.91B	+0.6%
Mar 2017	$5.87B	+0.2%
Dec 2016	$5.86B	-1.4%
Sep 2016	$5.94B	-1.5%
Jun 2016	$6.03B	-3.8%
Mar 2016	$6.27B	-1.8%
Dec 2015	$6.39B	-20.1%
Sep 2015	$7.99B	-1.5%
Jun 2015	$8.11B	+3.2%
Mar 2015	$7.86B	+1.7%
Dec 2014	$7.72B	+32.5%
Sep 2014	$5.83B	+6.1%
Jun 2014	$5.50B	+0.8%
Mar 2014	$5.46B	+1.9%
Dec 2013	$5.35B	+0.7%
Sep 2013	$5.31B	+3.4%
Jun 2013	$5.14B	+3.2%
Mar 2013	$4.98B	-0.2%
Dec 2012	$4.99B	+5.9%
Sep 2012	$4.71B	-23.6%
Jun 2012	$6.17B	+3.4%
Mar 2012	$5.96B	+1.2%
Dec 2011	$5.89B	+23.8%
Sep 2011	$4.76B	+114.5%
Jun 2011	$2.22B	+88.4%
Mar 2011	$1.18B	-

FAQ

What is the current TTM SG&A of ABBV?: As of today, ABBV TTM SG&A is -$64.93B
What is ABBV TTM SG&A most recent change?: ABBV TTM SG&A was down -9.86% on June 30, 2026
What is 1-year change in ABBV TTM SG&A?: ABBV TTM SG&A is down -544.56% year-over-year
How does ABBV TTM SG&A rank versus sector peers?: ABBV TTM SG&A is higher than 0.27% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on October 29, 2026

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Data Sources & References

ABBV Official Website www.abbvie.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv